Abeona Therapeutics (ABEO) Receives European Approval for ABO-102 Phase 1/2 in MPS 2A
Tweet Send to a Friend
Abeona Therapeutics, Inc. (NASDAQ: ABEO)Approval of clinical trial for ABO-102 (AAV-SGSH) in European Union marks 3rd regulatory approval for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
